Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis

Article Abstract:

A small, placebo-controlled clinical trial in which patients who were allergic to ragweed were immunized with a six-injection regimen of the AIC vaccine before the first ragweed season and evaluated during the next two ragweed seasons. The study provides preliminary evidence that a six-injection regimen of AIC reduces allergic rhinitis symptoms during the ragweed season and the clinical effects of AIC appear to be associated with the induction of long-lasting immune modulation.

Author: Creticos, Peter S., Hamilton, Robert G., Lindblad, Robert, Schroeder, John T., Balcer-Whaley, Susan, Khattignavong, Arouna P., Li, Henry, Coffman, Robert, Seyfert, Vicki, Eiden, Joseph J., Broide, David
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2006
Health aspects, Usage, Hay-fever, Immunotherapy, Allergic rhinitis, Ragweeds

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Safety and efficacy of a recombinant hepatitis E vaccine

Article Abstract:

The safety and efficacy of a hepatitis E virus (HEV) recombinant protein (rHEV) vaccine was evaluated in a phase 2, randomized, double-blind, placebo-controlled trial. Results suggested that in a high-risk population, the rHEV vaccine was effective in the prevention of hepatitis E.

Author: Endy, Timothy P., Innis, Bruce L., Shrestha, Mrigendra Prasad, Scott, Robert McNair, Joshi, Durga Man, Mammen, Mammen P., Jr., Thapa, Gyan Bahadur, Thapa, Narbada, Khin Saw Aye Myint, Fourneau, Marc, Kuschner, Robert A., Shrestha, Sanjay Kumar, David, Marie Pierre, Seriwatana, Jitvimol, Vaugn, David W., Safary, Assad
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2007
Hepatitis, Viral, Viral hepatitis, Hepatitis E virus

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The liver X receptor and atheroscelerosis

Article Abstract:

The research work related to liver X receptor (LXR)[beta]-specific agonist ligands is reviewed. LXR[beta] could be targeted for the treatment of atherosclerosis, which is the major cause of cardiovascular disease.

Author: Scott, James
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2007
Cardiovascular diseases, Atherosclerosis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Care and treatment, United States, Drug therapy, Causes of, Risk factors
Similar abstracts:
  • Abstracts: Therapeutic targeting of innate immunity with toll-like receptor agonists and antagonists. Anthrax delivers a lethal blow to host immunity
  • Abstracts: Integrin alphavbeta3 is a coreceptor for human cytomegalovirus. Detection of prions in blood
  • Abstracts: Beyond fraud - Stem-cell research continues. Tackling medical futility in Texas. The leading edge of stem cell therapeutics
  • Abstracts: Malignant hyperthermia: A case study. Virtual ICUs: Foundations for healthier environments
  • Abstracts: Dystocia increases with advancing maternal age. Quality of life and continence 1 year after the tension-free vaginal tape operation
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.